Want to see RXRX full AI Analyst Report?
ETFs with Recursion Pharmaceuticals (RXRX) Exposure
The following ETFs maintain exposure to Recursion Pharmaceuticals (RXRX). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
119 ETFs Hold Recursion Pharmaceuticals (RXRX)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in RXRX |
|---|---|---|---|---|---|---|
| AVUS | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | <0.01% | $29.96K | <0.01% |
| IWV | iShares Russell 3000 ETF | $20.56B | 0.20% | <0.01% | $684.70K | 0.03% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | <0.01% | $3.08M | 0.12% |
| SCHB | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | <0.01% | $1.35M | 0.05% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $66.07M | 2.68% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $179.36K | <0.01% |
| V3AL | Vanguard ESG Global All CapUCITS ETF USD | $638.31M | 0.26% | <0.01% | $37.06K | <0.01% |
| V3AA | Vanguard ESG Global All CapUCITS ETF AccumUSD | $1.28B | 0.26% | <0.01% | $37.06K | <0.01% |
| VT | Vanguard Total World Stock ETF | $84.28B | 0.06% | <0.01% | $1.73M | 0.07% |
| DFAS | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | <0.01% | $574.79K | 0.02% |
| AVUS | Avantis U.S. Equity ETF | $14.88B | 0.15% | <0.01% | $177.23K | <0.01% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $21.89K | <0.01% |
| DDUM | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | <0.01% | $3,154.56 | <0.01% |
| AVTM | Avantis Total Equity Markets ETF | $779.89M | 0.22% | <0.01% | $4,180.64 | <0.01% |
| DFAU | Dimensional US Core Equity Market ETF | $13.11B | 0.12% | <0.01% | $52.28K | <0.01% |
| AVSU | Avantis Responsible U.S. Equity ETF | $487.62M | 0.15% | <0.01% | $1,725.68 | <0.01% |
| WMSC | Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Accum USD | $555.95M | 0.27% | <0.01% | $626.4 | <0.01% |
| DFAC | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | <0.01% | $99.22K | <0.01% |
| DCOR | Dimensional US Core Equity 1 ETF | $3.70B | 0.14% | <0.01% | $14.74K | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in RXRX |
|---|---|---|---|---|---|---|
| AVUS | <0.01% | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | $29.96K | <0.01% |
| IWV | <0.01% | iShares Russell 3000 ETF | $20.56B | 0.20% | $684.70K | 0.03% |
| ITOT | <0.01% | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | $3.08M | 0.12% |
| SCHB | <0.01% | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | $1.35M | 0.05% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $66.07M | 2.68% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $179.36K | <0.01% |
| V3AL | <0.01% | Vanguard ESG Global All CapUCITS ETF USD | $638.31M | 0.26% | $37.06K | <0.01% |
| V3AA | <0.01% | Vanguard ESG Global All CapUCITS ETF AccumUSD | $1.28B | 0.26% | $37.06K | <0.01% |
| VT | <0.01% | Vanguard Total World Stock ETF | $84.28B | 0.06% | $1.73M | 0.07% |
| DFAS | <0.01% | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | $574.79K | 0.02% |
| AVUS | <0.01% | Avantis U.S. Equity ETF | $14.88B | 0.15% | $177.23K | <0.01% |
| DDGC | <0.01% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $21.89K | <0.01% |
| DDUM | <0.01% | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | $3,154.56 | <0.01% |
| AVTM | <0.01% | Avantis Total Equity Markets ETF | $779.89M | 0.22% | $4,180.64 | <0.01% |
| DFAU | <0.01% | Dimensional US Core Equity Market ETF | $13.11B | 0.12% | $52.28K | <0.01% |
| AVSU | <0.01% | Avantis Responsible U.S. Equity ETF | $487.62M | 0.15% | $1,725.68 | <0.01% |
| WMSC | <0.01% | Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Accum USD | $555.95M | 0.27% | $626.4 | <0.01% |
| DFAC | <0.01% | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | $99.22K | <0.01% |
| DCOR | <0.01% | Dimensional US Core Equity 1 ETF | $3.70B | 0.14% | $14.74K | <0.01% |
Popular ETF Comparisons
RXRX ETF Exposure FAQ
What ETFs hold Recursion Pharmaceuticals stock?
Recursion Pharmaceuticals (RXRX) is currently held by 119 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to RXRX include ARK (ARKG), First Trust (ROBT) and ARK (IT:ARKK).
Which ETF has the largest exposure to RXRX?
The ETF with the largest exposure to RXRX is ARK (ARKG), with approximately $63.65M in market value exposure.
How much RXRX stock is held by ETFs?
ETFs currently hold approximately $94.30M worth of Recursion Pharmaceuticals (RXRX) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.
